Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research
نویسندگان
چکیده
منابع مشابه
Management of patients with lung cancer and poor performance status.
Patients who are able to care for themselves but are unable to perform most work-related activities are considered to have a poor performance status (PS). Individuals who fulfill these criteria constitute a significant proportion of all patients with lung cancer. Patients with lung cancer and a poor PS, irrespective of age, have an increased incidence of adverse effects with therapy and poorer ...
متن کاملSystemic Therapy Options for Non–Small-Cell Lung Cancer in Patients with a Poor Performance Status
Discuss appropriate management strategies for patients with advanced non-small cell lung cancer (NSCLC) who have a poor performance status (PS). Explore the role of concurrent chemotherapy for locally advanced NSCLC in patients with a PS of 2. Review the single-agent, doublet, and molecularly targeted therapies under investigation for patients with advanced NSCLC with a poor PS. Appreciate the ...
متن کامل198Au grain implantation for early tongue cancer in patients of advanced age or poor performance status
Brachytherapy using (198)Au grains is minimally invasive and the only curative treatment for early tongue cancer in patients of advanced age or poor performance status available in our institution. From March 1993 to February 2008, (198)Au grains were used to treat a group of 96 Stage I-II tongue cancer patients who could not undergo surgery or brachytherapy using (192)Ir pins because of an adv...
متن کاملChemotherapy improves low performance status lung cancer patients.
The aim of the present study was to determine the potential benefit of conventional cisplatin-based chemotherapy on patients with advanced nonsmall cell lung cancer (NSCLC) and poor performance status (PS), defined as 60-70 on the Karnofsky scale. Retrospective analysis was carried out of a randomised trial performed in advanced NSCLC where 485 patients received three courses of gemcitabine+ifo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thoracic Oncology
سال: 2008
ISSN: 1556-0864
DOI: 10.1097/jto.0b013e3181622c17